News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
59,522 Results
Type
Article (6616)
Company Profile (12)
Press Release (52894)
Multimedia
Podcasts (43)
Webinars (2)
Section
Business (14820)
Career Advice (50)
Deals (2272)
Drug Delivery (11)
Drug Development (12114)
Employer Resources (13)
FDA (2002)
Job Trends (2242)
News (30708)
Policy (5131)
Tag
2027 Genetown Elite (1)
Academia (362)
Accelerated approval (5)
Adcomms (5)
Allergies (12)
Alliances (4979)
ALS (3)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (14)
Approvals (2029)
Artificial intelligence (27)
Autoimmune disease (18)
Automation (3)
Bankruptcy (28)
Best Places to Work (2084)
BIOSECURE Act (2)
Biosimilars (15)
Biotechnology (8)
Bladder cancer (20)
Brain cancer (3)
Breast cancer (48)
Cancer (435)
Cardiovascular disease (19)
Career advice (48)
CAR-T (44)
CDC (52)
Cell therapy (95)
Cervical cancer (8)
Clinical research (8882)
Collaboration (146)
Compensation (21)
Complete response letters (7)
COVID-19 (2145)
CRISPR (8)
C-suite (58)
Cystic fibrosis (16)
Data (582)
Denatured (4)
Depression (5)
Diabetes (18)
Diagnostics (378)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (20)
Drug pricing (20)
Drug shortages (2)
Duchenne muscular dystrophy (23)
Earnings (5015)
Editorial (24)
Employer branding (1)
Employer resources (12)
Events (7055)
Executive appointments (66)
FDA (2384)
Frontotemporal dementia (1)
Funding (124)
Gene editing (19)
Generative AI (3)
Gene therapy (61)
GLP-1 (79)
Government (1967)
Grass and pollen (2)
Guidances (36)
Healthcare (1723)
HIV (15)
IgA nephropathy (7)
Immunology and inflammation (25)
Immuno-oncology (10)
Indications (10)
Infectious disease (2348)
Inflammatory bowel disease (22)
Inflation Reduction Act (1)
Influenza (102)
Intellectual property (13)
Interviews (4)
IPO (995)
IRA (6)
Job creations (288)
Job search strategy (48)
JPM (11)
Labor market (5)
Layoffs (84)
Legal (488)
Liver cancer (2)
Lung cancer (35)
Lymphoma (52)
Management (7)
Manufacturing (127)
MASH (2)
Medical device (363)
Medtech (363)
Mergers & acquisitions (1359)
Metabolic disorders (71)
Multiple sclerosis (32)
Neurodegenerative disease (20)
Neuropsychiatric disorders (3)
Neuroscience (211)
NextGen: Class of 2026 (336)
Non-profit (331)
Now hiring (8)
Obesity (45)
Opinion (39)
Ovarian cancer (45)
Pain (9)
Pancreatic cancer (18)
Parkinson's disease (15)
Partnered (2)
Patents (50)
Patient recruitment (22)
Peanut (7)
People (4417)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase 1 (3123)
Phase 2 (3696)
Phase 3 (3360)
Pipeline (481)
Policy (114)
Postmarket research (385)
Preclinical (1204)
Press Release (19)
Prostate cancer (12)
Psychedelics (9)
Radiopharmaceuticals (13)
Rare diseases (91)
Real estate (492)
Recruiting (5)
Regulatory (3552)
Reports (11)
Research institute (390)
Resumes & cover letters (2)
RNA editing (5)
RSV (75)
Schizophrenia (4)
Series A (9)
Series B (10)
Service/supplier (1)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (3)
Sponsored (5)
Startups (272)
Supply chain (16)
Tariffs (18)
The Weekly (38)
Vaccines (1153)
Venture capital (8)
Weight loss (29)
Women's health (2)
Date
Today (13)
Last 7 days (51)
Last 30 days (174)
Last 365 days (2451)
2026 (248)
2025 (2492)
2024 (3142)
2023 (3752)
2022 (6872)
2021 (7810)
2020 (6266)
2019 (2774)
2018 (2123)
2017 (2121)
2016 (2107)
2015 (2561)
2014 (1987)
2013 (1618)
2012 (1811)
2011 (1950)
2010 (1810)
Location
Africa (165)
Alabama (38)
Alaska (1)
Arizona (7)
Asia (4079)
Australia (640)
California (608)
Canada (217)
China (78)
Colorado (31)
Connecticut (56)
Delaware (21)
Europe (9621)
Florida (68)
Georgia (65)
Hawaii (1)
Idaho (2)
Illinois (38)
India (17)
Indiana (41)
Iowa (3)
Japan (43)
Kansas (12)
Kentucky (4)
Louisiana (1)
Maine (1)
Maryland (331)
Massachusetts (474)
Michigan (10)
Minnesota (10)
Mississippi (1)
Missouri (4)
Montana (8)
Nebraska (2)
Nevada (1)
New Hampshire (1)
New Jersey (550)
New Mexico (3)
New York (272)
North Carolina (63)
North Dakota (8)
Northern California (274)
Ohio (17)
Pennsylvania (210)
Puerto Rico (1)
Rhode Island (7)
South America (100)
South Carolina (1)
Southern California (253)
Tennessee (6)
Texas (60)
United States (3023)
Utah (10)
Virginia (13)
Washington D.C. (6)
Washington State (66)
West Virginia (1)
Wisconsin (1)
59,522 Results for "eurocine vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Sanofi Suffers Another Sales Dip for ‘Gift to Public Health’ Vaccines
Sanofi’s vaccine sales dipped 2.5% in 2025, with almost all immunization products declining. Nevertheless, CEO Paul Hudson doubled down on his support for vaccine development.
January 29, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg
Growing opposition to vaccines in the U.S., driven by recent government policy changes, makes it difficult to see a return on investment in vaccine development, Moderna CEO Stéphane Bancel said this week.
January 23, 2026
·
2 min read
·
Tristan Manalac
Vaccines
JPM26: Sanofi’s CEO Keen To Buy the Dip as Vaccine Rhetoric Impacts Short-Term Sales
Buying vaccine biotech Dynavax was an easy choice for Sanofi despite anti-vaccine moves by the Trump administration.
January 14, 2026
·
3 min read
·
Annalee Armstrong
Editorial
All the Ways Moderna’s Flu Vaccine Rejection Letter Shocked Us
The FDA issued a rare Refusal-to-File letter to Moderna over its mRNA-based influenza vaccine application, in an unusual move that sent the biotech’s shares tumbling.
February 11, 2026
·
4 min read
·
Dan Samorodnitsky
Vaccines
Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence
Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.
January 30, 2026
·
2 min read
·
Tristan Manalac
Vaccines
FDA Refuses To Review Moderna’s mRNA Flu Vaccine, Claims Trial Inadequacies
After receiving a letter directly from CBER Director Vinay Prasad, Moderna said the FDA had previously signed off on the use of a licensed flu vaccine as a comparator for a Phase 3 study of mRNA-1010.
February 11, 2026
·
4 min read
·
Tristan Manalac
Vaccines
‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s ‘Anti-Science’ Vaccine Policies
Pfizer CEO Albert Bourla said that the main thing getting in the way of changing vaccine discussions in the U.S. is the Secretary of Health, Robert F. Kennedy, Jr.
January 22, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule
The US dramatically altered its recommendations for a series of vaccines, which drive billion-dollar earnings for giants like Merck and Pfizer.
January 6, 2026
·
3 min read
·
Dan Samorodnitsky
Podcast
Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More
Roche’s obesity candidate achieves 22.5% weight loss in Phase II; Moderna pulls the plug on late-stage vaccine trials as Health Secretary Robert F. Kennedy’s anti-vaccine policies and rhetoric continues; and embattled gene therapy maker Sarepta announces new data in Duchenne muscular dystrophy.
January 28, 2026
·
1 min read
·
Heather McKenzie
Regulatory
Experts Decry Prasad Memo’s Lack of Transparency as Vaccine Stocks Dip
With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief Vinay Prasad’s leaked vaccine memo.
December 2, 2025
·
4 min read
·
Dan Samorodnitsky
1 of 5,953
Next
